Articles

Sandoz receives complete response letter from the US FDA for proposed biosimilar rituximab

Achaogen Announces FDA Advisory Committee Voted Unanimously in Favor of Plazomicin for Treatment of Adults with Complicated Urinary Tract Infections

Achillion Reports First Quarter 2018 Financial Results and Management Transition

IONTAS and aTen Therapeutics Announce Collaboration to Discover Therapeutic Oncology Leads | Business Wire

Injecting Growth

Medtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants

Global Female Contraceptives Market to 2023 - CAGR Expected to Grow at 8.5% During the Forecast Period - ResearchAndMarkets.com | Business Wire

recommandation

BeiGene Appoints Senior Pharmaceutical Executive Dr. Xiaobin Wu as General Manager of China and President of BeiGene, Ltd.

Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma

Notis från Oasmia Pharmaceutical AB